Georgios Hadjigeorgiou
Professor, Neurologist, University Hospital of Larissa, Thessaly, Greece (Chairman, Dept. of Neurology)
School of Medicine
Administrative Staff
Academic Qualifications
Employment History
Publications
Journals reviewer
1.Sleep Medicine 2006 (1), 2007 (3), 2009 (4), 2010 (5), 2011 (5), 2012 (4), 2013 (3), 2014(2), 2015(3)
2.Cancer Detection and Prevention 2008 (1)
3.Neuroscience Letters 2007 (2), 2012(1), 2013 (1)
4.European Journal of Neurology 2008 (1),10 (1)
5.Molecular Biology Reports 2008 (1)
6.Annals of Human Genetics 2008 (1)
7.American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2009 (1)
8.Arthritis & Rheumatism 2009 (1)
9.NeuroMolecular Medicine 2009 (1)
10.Neurogenetics 2009 (1)
11.Journal of Neurological Research 2011 (1)
12.European Neurology 2011 (1)
13.Fundamental & Clinical Pharmacology 2011 (1)
14.Journal of Neuroinfammation 2011 (1)
15.PLoS ONE 2011 (1)
16.Human immunology 2012 (2), 2013 (1), 2014(1)
17.Neurological Science 2012 (1)
18.Journal of the Neurological Sciences 2012 (2)
19.BMJ Open 2012 (1)
20.BMC Research Notes 2012 (1)
21.Toxicology 2012 (1); 2013 (1)
22.IOVS (Investigative Opthalmology & Visual Science) 2012 (1)
23.Molecular Genetics & Metabolism 2012 (1)
24.BMC Neurology 2013 (1)
25.GENE 2013(1)
26.European Journal of Neurology 2013 (1)
27.British Microbiology Research Journal 2014 (1)
28.Journal of the Neurological Sciences 2014(1)
29.Movement Disorders 2014 (1), 2015 (1)
Publications:
GuidelinesGarcia-Borreguero D, Silber MΗ, Winkelman, JW, Högl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y, Manconi M, Oertel W, Οndo W, Winkelmann J, Allen RP. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: A combined task force othe IRLSSG, EURLSSG, and the RLS-foundation.Sleep Medicine. 2016; 21:1-11, 1 May. IF2014=3.154, Citations=1Kaditis DG, Zintzaras E, Sali D, Kotoulas G, Papadimitriou A, Hadjigeorgiou GM. Conjugate eye deviation as predictor of acute cortical and subcortical ischemic brain lesions.Clin Neurol Neurosurg. 2016 Apr;143:80-5. doi:10.1016/j.clineuro.2016.02.011. IF2014=1.127, Ciatations=0
Hadjigeorgiou GF, Singh R, Dardiotis E, Paterakis K, Hadjigeorgiou GM, Fountas KN. Traumatic brain injury and gene knockout animal models: an up-to-date review.J Neurosurg Sci. 2016 Jan 20. [Epub ahead of print] IF2014=1.158, Citations=0Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Kilidireas C, Voumvourakis K, Dardiotis E; HELANI (Hellenic Academy of Neuroimmunology). The Effect of Disease ModifyingTherapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.PLoS One. 2015 Dec 7;10(12):e0144538. doi: 10.1371/journal.pone.0144538. IF2014=3.234, Citations=5
Meta-analysis Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Dardiotis E, Kilidireas C, Voumvourakis K; HELANI (Hellenic Academy of Neuroimmunology). The effect of disease-modifying therapies onbrain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis.Ther Adv Neurol Disord. 2015 Sep;8(5):193-202. doi: 10.1177/1756285615600381. IF2014=3.140, Citations=1
Original Article Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos I, Psimadas D, Fezoulidis I, Kapsalaki E, Hadjigeorgiou G,Georgoulias P. Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer's Disease.J Alzheimers Dis. 2015;47(3):773-85. doi: 10.3233/JAD-150068. IF2014=4.151, Citations=0
Original Article Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium. Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. IF2014=8.286, Citations=0
Original Article Stefanidis I, Vainas A, Giannaki CD, Dardiotis E, Spanoulis A, Sounidaki M, Eleftheriadis T, Liakopoulos V, Karatzaferi C, Sakkas GK, Zintzaras E, Hadjigeorgiou GM. Restless legs syndrome does not affect 3-year mortality in hemodialysipatients.Sleep Med. 2015 Sep;16(9):1131-8. doi:10.1016/ j.sleep. 2015.04.023. IF2014=3.154, Citations=0
Original Article Giannaki CD, Sakkas GK, Karatzaferi C, Maridaki MD, Koutedakis Y, Hadjigeorgiou GM, Stefanidis I. Combination ofExercise Training and Dopamine Agonists in Patients with RLS on Dialysis: A Randomized, Double-Blind Placebo-Controlled Study.ASAIO J. 2015 Nov-Dec;61(6):738-41. doi: 10.1097/MAT.0000 000000000271. IF2014 = 1.516, Citaions=0
Original Article Dardiotis E, Paterakis K, Siokas V, Tsivgoulis G, Dardioti M, Grigoriadis S, Simeonidou C, Komnos A, Kapsalaki E, Fountas K, Hadjigeorgiou GM. Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury.Pharmacogenet Genomics. 2015 Oct;25(10):485-90. doi: 10.1097/FPC.0000000000000161.IF2014=3.481, Citations=0
Original Article Theotokis P, Kleopa KA, Touloumi O, Lagoudaki R, Lourbopoulos A, Nousiopoulou E, Kesidou E, Poulatsidou KN,Dardiotis E, Hadjigeorgiou G, Karacostas D, Cifuentes-Diaz C, Irinopoulou T, Grigoriadis N. Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitis.Glia. 2015 Apr 27. doi: 10.1002/glia.22843. [Epub ahead of print] IF2014=6.031, Citations=0
ReviewSakkas GK, Giannaki CD, Karatzaferi C, Maridaki M, Koutedakis Y, Hadjigeorgiou GM, Stefanidis I. Current trends in the management of uremic restless legs syndrome: a systematic review on aspects related to quality of life, cardiovascular mortality and survival.Sleep Med Rev. 2015;21:39-49
Nalls MA, Bras J, Hernandez DG, Keller MF, Majounie E, Renton AE, Saad M, Jansen I, Guerreiro R, Lubbe S, Plagnol V, Gibbs JR, Schulte C, Pankratz N, Sutherland M, Bertram L, Lill CM, DeStefano AL, Faroud T, Eriksson N, Tung JY, Edsall C, Nichols N, Brooks J, Arepalli S, Pliner H, Letson C, Heutink P, Martinez M, Gasser T, Traynor BJ, Wood N, Hardy J, Singleton AB; International Parkinson's Disease Genomics Consortium (IPDGC); Parkinson's Disease meta-analysis consortium. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases.
Neurobiol Aging. 2015;36(3):1605.e7-12. IF2014=5.013, Citations=0
Consesus paper Puschmann A, Brighina L, Markopoulou K, Aasly J, Chung SJ, Frigerio R, Hadjigeorgiou G, Kõks S, Krüger R, Siuda J, Wider C, Zesiewicz TA, Maraganore DM. Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statementParkinsonism Relat Disord. 2015;21(7):675-82 IF2014=3.972, Citations=0
Original Article Gratsias G, Kapsalaki E, Kogia S, Dardiotis E, Tsimourtou V, Lavdas E, Kousi E, Pelekanou A, Hadjigeorgiou GM, Fezoulidis I. A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T.Acta Neurol Belg. 2015;115(2):111-6 IF2014=0.894, Citations=0
Original Article Hadjigeorgiou G, Dardiotis E, Tsivgoulis G, Doskas T, Petrou D, Makris N, Vlaikidis N, Thomaidis T, Kyritsis A, Fakas N, Treska X, Karageorgiou C, Sotirli S, Giannoulis C, Papadimitriou D, Mylonas I, Kouremenos E, Vlachos G, Georgiopoulos D, Mademtzoglou D, Vikelis M, Zintzaras E. Observational study assessing demographic, economic and clinical factorassociated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).PLoS One. 2014;9(11):e113933. IF2014=3.234, Citations=0
Original Article Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos I, Psimadas D, Kapsalaki E, Fezoulidis I, Hadjigeorgiou G, Georgoulias P. Brain perfusion SPECT with Brodmann areas analysis in differentiatingfrontotemporal dementia subtypes.Curr Alzheimer Res. 2014;11(10):941-54. IF2014=3.889, Citations=0
Original Article Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M, Krüger R, Lesage S, Brice A, Chung SJ, Kim MJ, Kim YJ, Ross OA, Wszolek ZK, Rogaeva E, Xi Z, Lang AE, Klein C, Weissbach A, Mellick GD, Silburn PA, Hadjigeorgiou GM, Dardiotis E, Hattori N, Ogaki K, Tan EK, Zhao Y, Aasly J, Valente EM, Petrucci S, Annesi G, Quattrone A, Ferrarese C, Brighina L, Deutschländer A, Puschmann A, Nilsson C, Garraux G, LeDoux MS, Pfeiffer RF, Boczarska-Jedynak M, Opala G, Maraganore DM, Engelborghs S, De Deyn PP, Cras P, Cruts M, Van Broeckhoven C; GEO-PD Consortium. Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.Neurology. 2014;83(21):1906-13 IF2014=8.286, Citations=0
Original Article Zacharaki F, Hadjigeorgiou GM, Koliakos GG, Morrison MA, Tsezou A, Chatzoulis DZ, Almpanidou P, Topouridou K, Karabatsas CH, Pefkianaki M, DeAngelis MM, Tsironi EE. Plasma homocysteine and genetic variants of homocysteine metabolism enzymes in patients from central Greece with primary open-angle glaucoma and pseudoexfoliation glaucoma. Clin Ophthalmol. 2014;8:1819-25 IF2014=0.000, Citations=0
Mouzas OD, Zibis AH, Bonotis KS, Katsimagklis CD, Hadjigeorgiou GM, Papaliaga MN, Dimitroulias AP, Malizos KN.Psychological distress, personality traits and functional disability in patients with osteonecrosis of the femoral head.J Clin Med Res. 2014;6(5):336-44 IF2014=0.000, Citations=0
Zintzaras E, Miligkos M, Ziakas P, Balk EM, Mademtzoglou D, Doxani C, Mprotsis T, Gowri R, Xanthopoulou P, Mpoulimari I, Kokkali C, Dimoulou G, Rodopolou P, Stefanidis I, Kent DM, Hadjigeorgiou GM. Assessment of the relative effectiveness and tolerability of treatments of type 2 diabetes mellitus: a network meta-analysis.Clin Ther. 2014;36(10):1443-53.e9.IF2014=2.731, Citations=1
Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, Lee JH, Cheng R; International Parkinson's Disease Genomics Consortium (IPDGC); Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI); 23andMe; GenePD; NeuroGenetics Research Consortium (NGRC); Hussman Institute of Human Genomics (HIHG); Ashkenazi Jewish Dataset Investigator; Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC); Greek Parkinson's Disease Consortium; Alzheimer Genetic Analysis Group, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.Nat Genet. 2014;46(9):989-93
Dardiotis E, Kosmidis MH, Yannakoulia M, Hadjigeorgiou GM, Scarmeas N. The Hellenic Longitudinal Investigation of Aging and Diet (HELIAD): rationale, study design, and cohort description.
Neuroepidemiology. 2014;43(1):9-14
Chung SJ, Biernacka JM, Armasu SM, Anderson K, Frigerio R, Aasly JO, Annesi G, Bentivoglio AR, Brighina L, Chartier-Harlin MC, Goldwurm S, Hadjigeorgiou G, Jasinska-Myga B, Jeon BS, Kim YJ, Krüger R, Lesage S, Markopoulou K, Mellick G, Morrison KE, Puschmann A, Tan EK, Crosiers D, Theuns J, Van Broeckhoven C, Wirdefeldt K, Wszolek ZK, Elbaz A, Maraganore DM; Genetic Epidemiology of Parkinson's Disease Consortium. Alpha-synuclein repeat variants and survival in Parkinson's disease.Mov Disord. 2014;29(8):1053-7 IF2014=5.680, Citations=3
Original Article Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin MC, Dardiotis E, Destée A, Ferrarese C, Ferraris A, Fiske B, Gispert S, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lin CH, Lohmann K, Loriot MA, Lynch T, Mellick GD, Mutez E, Opala G, Park SS, Petrucci S, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Tomiyama H, Uitti RJ, Valente EM, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Xiromerisiou G, Maraganore DM, Farrer MJ, Ross OA; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.Neurobiol Aging. 2014;35(1):266.e514 IF2014=5.013, Citations=0Original Article Bozi M, Papadimitriou D, Antonellou R, Moraitou M, Maniati M, Vassilatis DK, Papageorgiou SG, Leonardos A, Tagaris G, Malamis G, Theofilopoulos D, Kamakari S, Stamboulis E, Hadjigeorgiou GM, Athanassiadou A, Michelakakis H, Papadimitriou A, Gasser T, Stefanis L. Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.Eur J Neurol. 2014;21(7):963-8 IF2014=4.055, Citations=2
Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, Pantzaris MC, Stefanidis I, Sakkas GK. Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review.Kidney Int. 2014;85(6):1275-82 IF2014=8.563, Citations=6
Kara E, Xiromerisiou G, Spanaki C, Bozi M, Koutsis G, Panas M, Dardiotis E, Ralli S, Bras J, Letson C, Edsall C, Pliner H, Arepalli S, Kalinderi K, Fidani L, Bostantjopoulou S, Keller MF, Wood NW, Hardy J, Houlden H, Stefanis L, Plaitakis A, Hernandez D, Hadjigeorgiou GM, Nalls MA, Singleton AB. Assessment of Parkinson's disease risk loci in Greece.Neurobiol Aging. 2014;35(2):442.e9-442.e16 IF2014=5.013, Citations=0
ACST-2 Collaborative Group, Halliday A, Bulbulia R, Gray W, Naughten A, den Hartog A, Delmestri A, Wallis C, le Conte S, Macdonald S. Status update and interim results from the asymptomatic carotid surgery trial-2 (ACST-2).
Eur J Vasc Endovasc Surg. 2013;46(5):510-8 IF2014=2.490, Citations=7
Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, Maridaki MD, Koutedakis Y, Founta P, Tsianas N, Stefanidis I, Sakkas GK. A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome.Nephrol Dial Transplant. 2013;28(11):2834-40 IF2014=3.577, Citations=3
Heckman MG, Soto-Ortolaza AI, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Boczarska-Jedynak M, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Petrucci S, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, Van Broeckhoven C, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Hentati F, Farrer MJ, Ross OA; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Mov Disord. 2013;28(12):1740-4 IF2014=5.680, Citations=0
Giannaki CD, Karatzaferi C, Hadjigeorgiou GM, George KP, Stefanidis I, Sakkas GK. Periodic limb movements in sleep and cardiovascular disease: time to act. Front Neurol. 2013;22;4:97
Hadjigeorgiou GM, Doxani C, Miligkos M, Ziakas P, Bakalos G, Papadimitriou D, Mprotsis T, Grigoriadis N, Zintzaras E. A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis. J Clin Pharm Ther. 2013;38(6):433-9 IF2014=1.668, Citations=6
Oroginal Article Dardiotis E, Panayiotou E, Feldman ML, Hadjisavvas A, Malas S, Vonta I, Hadjigeorgiou G, Kyriakou K, Kyriakides T.Intraperitoneal melatonin is not neuroprotective in the G93ASOD1 transgenic mouse model of familial ALS and may exacerbate neurodegeneration Neurosci Lett. 2013;548:170-5IF2014=2.030, Citations=3
Original Article Stefanidis I, Vainas A, Dardiotis E, Giannaki CD, Gourli P, Papadopoulou D, Vakianis P, Patsidis E, Eleftheriadis T,Liakopoulos V, Pournaras S, Sakkas GK, Zintzaras E, Hadjigeorgiou GM. Restless legs syndrome in hemodialysis patients: an epidemiologic survey in Greece. Sleep Med. 2013;14(12):1381-6 IF2014=3.154, Citations=3
Original Article Sali D, Verganelakis DA, Gotsis E, Toulas P, Papatriantafillou J, Karageorgiou C, Thomaides T, Kapsalaki EZ, Hadjigeorgiou G, Papadimitriou A. Diffusion tensor imaging (DTI) in the detection of white matter lesions in patients with mild cognitive impairment (MCI).Acta Neurol Belg. 2013;113(3):369 IF2014=0.894, Citations=2
Original Article Giannaki CD, Zigoulis P, Karatzaferi C, Hadjigeorgiou GM, George KP, Gourgoulianis K, Koutedakis Y, Stefanidis I, SakkasGK. Periodic limb movements in sleep contribute to further cardiac structure abnormalities in hemodialysis patients with restless legs syndrome.J Clin Sleep Med. 2013;9(2):147-53 IF2014=3.053, Citations=8
Original Article Zacharaki D, Lagoudaki R, Touloumi O, Kotta K, Voultsiadou A, Poulatsidou KN, Lourbopoulos A, Hadjigeorgiou G, Dardiotis E, Karacostas D, Grigoriadis N. Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells isolated from experimental autoimmune encephalomyelitis mice. J Mol Neurosci. 2013;51(2):282-97 IF2014=2.343, Citations=2
Original Article Giannaki CD, Sakkas GK, Karatzaferi C, Hadjigeorgiou GM, Lavdas E, Kyriakides T, Koutedakis Y, Stefanidis I. Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study. BMC Nephrol. 2013;14:194 IF2014=1.690, Citations=3
ReviewDardiotis E, Xiromerisiou G, Hadjichristodoulou C, Tsatsakis AM, Wilks MF, Hadjigeorgiou GM. The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides.
LetterXiromerisiou G, Dardiotis E, Tsironi EE, Hadjigeorgiou G, Ralli S, Kara E, Petalas A, Tachmitzi S, Hardy J, Houlden H. THAP1 mutations in a Greek primary blepharospasm series. Parkinsonism Relat Disord. 2013;19(3):404-5IF2014=3.972, Citations=3
Original Article Kokouva M, Koureas M, Dardiotis E, Almpanidou P, Kalogeraki A, Kyriakou D, Hadjigeorgiou GM, Hadjichristodoulou C.Relationship between the paraoxonase 1 (PON1) M55L and Q192R polymorphisms and lymphohaematopoietic cancers in a Greek agricultural population. Toxicology. 2013;307:12-6 IF2014=3.621, Citations=2
Short ReportSharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Bertram L, Bozi M, Barcikowska M, Crosiers D, Clarke CE, Facheris MF, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon BS, Jamrozik Z, Krygowska-Wajs A, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Libioulle C, Murata M, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Meitnger T, Zimprich A, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Strom TM, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Van Broeckhoven C, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yomono HS, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEOPD consortium. A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.J Med Genet. 2012;49(11):721-6IF2014=6.335, Citations=23
Original Article Gkizlis V, Giannaki CD, Karatzaferi C, Hadjigeorgiou GM, Mihas C, KoutedakisY, Stefanidis I, Sakkas GK. Uremic Versus Idiopathic Restless Legs Syndrome: Impact on Aspects Related to Quality of Life.ASAIO J. 2012 Nov-Dec;58(6):607-11 IF2014=1.516, Citations=4
Original Article Tsironi EE, Dastridou AI, Katsanos A, Dardiotis E, Veliki S, Patramani G, Zacharaki F, Ralli S, Hadjigeorgiou GM Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease.BMC Opthalmol 2012; 12(1):54 IF2014=1.020, Citations=11
Original Article Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos I, Kapsalaki E, Hadjigeorgiou G, Georgoulias P. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer's disease from frontotemporal degeneration syndromes. Nucl Med Commun. 2012;33(12):1267-76 IF2014=1.669, Citations=1
Original Article Almpanidou P, Hadjigeorgiou G, Gourgoulianis K, Papadimitriou A. Association of tumor necrosis factor-α gene polymorphism (-308) and obstructive sleep apnea-hypopnea syndrome. Hippokratia. 2012;16(3):217-20.
BOOKS and CHAPTERS
English
- DiMauro S, Bruno S, Andreu AL, Hadjigeorgiou GM, Shanske S. New aspects of metabolic myopathies. In: Muscle exercise intolerance and muscle contracture. Serratrice G, Pouget J,Azulay J-Ph, eds, Springer-Verlag France 1999; pp 33-43.
- Hadjigeorgiou GM. Muscle phosphoglycerate mutase. In: Encyclopedia of Molecular Mechanisms of Disease. Lang N, ed, Springer (2009).
- Stefanidis I, Hadjigeorgiou GM. Muscle phosphoglycerate kinase. In: Encyclopedia of Molecular Mechanisms of Disease. Lang N, ed, Springer (2009).
- Dardiotis E, Hadjigeorgiou GM, Fountas KN. Pineal Gland: Neurobiology, Physiology and Molecular Pathways. In
Pineal Gland: recent advances in development, imaging, disease and treatment, pp 439-458, by Turgut M and Kumar R (editors). Nova Science Publishers, New York, 2011. ISBN 978-1-60876-717-5.
- Dardiotis E, Karanikas V, Paterakis K, Fountas K & Hadjigeorgiou GM. Traumatic brain injury and inflammation: emerging role of innate and adaptive immunity. In: Brain injury-Pathogenesis, Monitoring, Recovery and Management, pp 23-28, by Amit Agrawal (ed.). InTech Publishers 2012 (http://www.intechopen.com/books/brain-injury-pathogenesis-monitoring-recovery-and-management) . ISBN: 978-953-51-0265-6
- DiMauro S, Tsujino S, and Hadjigeorgiou GM. Myophosphorylase deficiency. In Medlink (Neurology > Metabolic disorders in childhood > Glycogen storage diseases > Myophosphorylase deficiency) Author: James Godwin (http://medlink.com) 2000-2014 (last update 2011).
- DiMauro S, Tsujino S, and Hadjigeorgiou GM. Acid maltase deficiency. In Medlink (Neurology > Metabolic disorders in childhood > Glycogen storage diseases > Acid maltase deficiency) Author: James Godwin (http://medlink.com) 2000-2014 (last update 2011).
- DiMauro S, Tsujino S, and Hadjigeorgiou GM. Muscle phosphofructokinase deficiency. In Medlink (Neurology > Metabolic disorders in childhood > Glycogen storage diseases > Acid maltase deficiency) Author: James Godwin (http://medlink.com) 2000-2014 (last update 2011).
Greek
- Χατζηγεωργίου Γ. Κρανιοεγκεφαλικές κακώσεις: τα επιμέρους του συνόλου. Editor. Ιατρικές Εκδόσεις Κωνσταντάρας 2015. ISBN: 978-960-6802-90-4
- Χατζηγεωργίου Γ, Κονιτσιώτης Σπύρος. Σύνδρομο Ανήσυχων Ποδιών (τα βασικά του συνδρόμου) [Restless Legs Syndrome]. Editor. Ιατρικές Εκδόσεις Βαγιονάκης 2006 (ISBN:960-7940-90-3).
- Χατζηγεωργίου Γ. Γενετική των νοσημάτων της τ πρωτεΐνης [Genetics of tauopathies]. Στο βιβλίο: Άνοια – Ιατρική και
Κοινωνική πρόκληση. Εκδότες: Μ. Τσολάκη και Α. Κάζης, University Studio Press, Θεσσαλονίκη 2005, σελ. 73-78.
- Χατζηγεωργίου Γ. Γενετική των κεφαλαλγιών [Genetics of headaches]. Στο βιβλίο: Κεφαλαλγίες. 2η έκδ. Εκδότης: . Μητσικώστας, BHTA Medical Editions, Αθήνα 2004 (ISBN 960-8071-65-8) σελ. 59-74.
- Χατζηγεωργίου Γ. και Παπαδημητρίου Α. Σημειώσεις Νευρογενετικής [Notes for Neurogenetics] για το κατ’ επιλογήν μάθημα “Νευρογενετική” και για το πρόγραμμα ΠΣΕ “Ιατρική Βιοχημεία”.
- Χατζηγεωργίου ΓΜ. Μελέτη Pd2+ και Cd2+, ακετυλοχολινεστεράσης και μιτοχονδριακών ενζύμων σε γραμμωτούς μύες. Διδακτορκή Διατριβή 1998.
- Παπαδημητρίου Α, Χατζηγεωργίου ΓΜ. Πλασμαφαίρεση και ενδοφλέβια χορήγηση γ-σφαιρίνης στη θεραπεία αυτοάνοσων νευρολογικών νοσημάτων [IVIG for autoimmune diseases]. Στη μονογραφία: Πρόσφατες εξελίξεις στη
Exhibitions
Research Projects
Department of Neurosurgery (Assoc. Prof. K. Fountas and Assist. Prof. K. Paterakis)
Dardiotis E, et al. AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury. J NEUROTRAUMA 2014;31(23):1920-6
Kapsalakis IZ, et al. Preoperative evaluation with FMRI of patients with intracranial gliomas. RADIOL RES PRACT 2012; Jul 12 [Epub ahead of print] PubMed PMID: 22848821. Article
Fountas KN, et al . Role of endoscopic third ventriculostomy in treatment of selected patients with normal pressure hydrocephalus. ACTA NEUROCHIR SUPPL 2012;113:129-33, Article.
Dardiotis E, et al. Angiotensin-converting enzyme tag SNPs in patients with intracerebral hemorrhage. PHARMACOGENETICS AND GENOMICS 2011;21(3):136-41, Article.
Karathanou A, et al. Biochemical markers analyzed using microdialysis and traumatic brain injury outcomes. J NEUROSURG SCI 2011;55(3):173-7, Article.
Fountas KN, Cerebellar stimulation in the management of medically intractable epilepsy: a systematic and critical review.NEUROSURGICAL FOCUS 2010;29(2):E8. Review.
Xiromerisiou G, et al. Genetic basis of Parkinson disease. NEUROSURGICAL FOCUS 2010;28:E7, Review.
Dardiotis E, et al. Genetic association studies in patients with traumatic brain injury patients. NEUROSURGICAL FOCUS 2010;28:E9.1-E9.12, Review.Dardiotis E, et al. Genetic susceptibility to primary intracerebral haemmorhage. EUROPEAN NEUROLOGICAL REVIEW 2009;4(1): 44-48, Review.
Dardiotis E, et al. Alpha-1 antichymotrypsin gene signal peptide A/T polymorphism and primary intracerebral hemorrhage. EUROPEAN NEUROLOGY 2008;59:307-314, Article.
Hadjigeorgiou GM, et al. Low RLS prevalence and awareness in central Greece: an epidemiological survey. EUROPEAN JOURNAL OF NEUROLOGY 2007;14:1275-1280, Article.
Paterakis KN, et al. Primary spinal intradural extramedullary cysticercosis. SURGICAL NEUROLOGY 2007;68:309-311, Case Report.
Paterakis KN, et al. Cervical spinal cord intramedullary teratoma. CLINICAL NEUROLOGY & NEUROSURGERY 2006;108;514-517, Case Report.
Dardiotis E, et al. Lack of association between the IL-1 gene (-889) polymorphism and outcome after head injury. SURGICAL NEUROLOGY 2006;66:334-335, Letter.
Paterakis KN, et al. Retroclival epidural hematoma secondary to a longitudinal clivus fracture. CLINICAL NEUROLOGY & NEUROSURGERY 2005;108:67-72, Case Report.
Hadjigeorgiou GM, et al. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury. NEUROLOGY 2005;65:1077-1082, Article.
Department of Nephrology (Prof. I. Stefanidis)
Department of physical education & sport science (Prof. I. Koutedakis and Dr G. Sakkas)
Sakkas GK, et al. Current trends in the management of uremic restless legs syndrome: a systematic review on aspects related to quality of life, cardiovascular mortality and survival. SLEEP MEDICINE REV 2015;21:39-49
Stefanidis I, et al. Association between the interleukin-1β Gene (IL 1B) C-511T polymorphism and the risk of diabetic nephropathy in type 2 diabetes: a candidate-gene association study. DNA CELL BIOL. 2014;33(7):463-8
Giannaki CD, et al. Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review. KIDNEY INT 2014;85(6):1275-82
Stefanidis I, et al. Restless legs syndrome in hemodialysis patients: an epidemiologic survey in Greece. SLEEP MED 2013;14(12):1381-6
Giannaki CD, et al. Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study. BMC NEPHROL 2013;14:194
Giannaki CD, et al. Periodic limb movements in sleep and cardiovascular disease: time to act. FRONT NEUROL 2013;22;4:97
Giannaki CD, et al. A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome. NEPHROL DIAL TRANSPLANT 2013;28(11):2834-40
Giannaki CD, et al. Periodic limb movements in sleep contribute to further cardiac structure abnormalities in hemodialysis patients with restless legs syndrome. J CLIN SLEEP MED 2013;9(2):147-53
Gkizlis V, et al. Uremic Versus Idiopathic Restless Legs Syndrome: Impact on Aspects Related to Quality of Life. ASAIO J,2012;58(6):607-11
Giannaki CD, et al. Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome. PLOS One 2011;6(10):e25180 Article.Schormair Β, et al. MEIS1 and BTBD9 - genetic association with RLS in ESRD patients. JOURNAL OF MEDICAL GENETICS;48(7):462-6, Article.
Giannaki CD, et al. Non-Pharmacological Management of Periodic Limb Movements During Hemodialysis Session in Patients With Uremic Restless Legs Syndrome. ASAIO JOURNAL 2010;56:538-542, Article.
Giannaki CD, et al. Quality of Life Score Is Primarily Affected by the Mental Rather than the Physical Component in Patients with Restless Legs Syndrome. MOVEMENT DISORDERS 2010;25:135-136, Letter.
Sakkas GK, et al. Haemodialysis patients with sleep apnoea syndrome experience increased central adiposity and altered muscular composition and functionality. NEPHROLOGY DIALYSIS TRANSPLANTATION 2008;23:336-344, Article.
Sakkas GK, et al. Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study. ASAIO JOURNAL 2008;54:185-190. Article.
Hadjigeorgiou GM, et. al. Low RLS prevalence and awareness in central Greece: an epidemiological survey. EUROPEAN JOURNAL OF NEUROLOGY 2007;14:1275-1280, Article.
Laboratory of Biomathematics. (Assoc. prof. E. Zintzaras)
Hadjigeorgiou GM, et al. A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis. J CLIN PHARM THER 2013;38(6):433-9
Zintzaras E, et al. Assessment of the relative effectiveness and tolerability of treatments of type 2 diabetes mellitus: a network meta-analysis. CLIN THER 2014;36(10):1443-53.e9.
Hadjigeorgiou G, et ak. Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA). PLOS ONE. 2014;9(11):e113933.
Zintzaras E, et al. A network analysis of randomized controlled trials in multiple sclerosis. CLINICAL TEHRAPEUTICS 2012; 34(4):857-869 Meta-analysis.
Michalakaki E, et al. Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease. MOVEMENT DISORDERS 2012 Jan 5 [Epub ahead of print] Article.
Zintzaras E, et al. Randomized Trials of Dopamine Agonists in Restless Legs Syndrome: A Systematic Review, Quality Assessment, and Meta-Analysis. CLINICAL THERAPEUTICS 2010;32:221-237, Review.Dardiotis E, et al. Alpha-1 antichymotrypsin gene signal peptide a/t polymorphism and primary intracerebral hemorrhage. EUROPEAN NEUROLOGY 2008;59:307-314. Article.
Hadjigeorgiou GM, et al. Low RLS prevalence and awareness in central Greece: an epidemiological survey. EUROPEAN JOURNAL OF NEUROLOGY 2007;14:1275-1280, Article.
Zintzaras E, Hadjigeorgiou GM. The role of G196A polymorphism in the brain-derived neurotrophic factor (BDNF) gene in the cause of Parkinson’s disease: a meta-analysis JOURNAL OF HUMAN GENETICS 2005;50:560-566, Article.
Hadjigeorgiou GM, et al. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury. NEUROLOGY 2005;65:1077-1082.
Zintzaras E, Hadjigeorgiou GM. Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. JOURNAL OF HUMAN GENETICS 2004;49: 474-481, Article.
Department of Orthopaedics (Prof. K. Malizos)
Mouzas OD, et al. Psychological distress, personality traits and functional disability in patients with osteonecrosis of the femoral head. J CLIN MED RES 2014;6(5):336-44
Dimitroulias A, et al. White matter lesions in femoral head osteonecrosis patients: manifestation of vascular disease or not? HIPPOKRATIA 2011;15(3):265-268 Article.
Hadjigeorgiou GM, et al. Genetic association studies in Osteonecrosis of the femoral head. Mini review of the literature. SKELETAL RADIOLOGY 2008;37(1):1-7, Review.
Hadjigeorgiou GM, et al. Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions. JOURNAL OF ORTHOPAEDICS RESERCH 2007;25:1087-1093, Article.
Tsezou A, et al. Absence of linkage to chromosomes 6q and 16p in a Greek population with knee osteoarthritis. JOURNAL OF ORTHOPAEDIC RESEARCH 2006;24:1900-1905, Article.
Hadjigeorgiou GM, et al. Increased frequency of white matter lesions in patients with osteonecrosis (WMLeOn) of the femoral head. EUROPEAN JOURNAL OF RADIOLOGY 2004;50:278-284, Article.
Department of Pulmonology (Prof. K. Gourgoulianis)
Giannaki CD, et al. Periodic limb movements in sleep contribute to further cardiac structure abnormalities in hemodialysis patients with restless legs syndrome. J CLIN SLEEP MED 2013;9(2):147-53
Xiromeritis AG, et al. Quantitative spectral analysis of vigilance EEG in patients with obstructive sleep apnoea syndrome : EEG mapping in OSAS patients. SLEEP BREATH 2011;15(1):121-8.
Sakkas GK, et al.Haemodialysis patients with sleep apnoea syndrome experience increased central adiposity and altered muscular composition and functionality. NEPHROLOGY DIALYSIS TRANSPLANTATION 2008;23:336-344, Article
Hadjigeorgiou GM, et al. Low RLS prevalence and awareness in central Greece: an epidemiological survey. EUROPEAN JOURNAL OF NEUROLOGY 2007;14:1275-1280, Article.
Department of Hygiene and Epidemiology (Assoc. Prof. C. Hadjichristodoulou)
Kokouva M, et al. Relationship between the paraoxonase 1 (PON1) M55L and Q192R polymorphisms and lymphohaematopoietic cancers in a Greek agricultural population. TOXICOLOGY 2012 Jul 16. [Epub ahead of print] PubMed PMID: 22800774. Article
Kokouva M, et al. Pesticide exposure and lymphohaematopoietic cancers: a case-control study in an agricultural region (Larissa, Thessaly, Greece). BMC PUBLIC HEALTH 2011; 4:11:5, Article.
Collaboration with other Faculties of Medicine and Reseach Center in Greece
Department of Neurology, Faculty of Medicine, University of Ioannina (Assoc. Prof. S. Konitsiotis)
Margariti PN, et al. Investigation of Unmedicated Early Onset Restless Legs Syndrome by Voxel-Based Morphometry, T2 Relaxometry, and Functional MR Imaging during the Night-Time Hours. AM J NEURORADIOL 2012; 33(4):667-672. Article.
Zintzaras E, et al. Randomized Trials of Dopamine Agonists in Restless Legs Syndrome: A Systematic Review, Quality Assessment, and Meta-Analysis. CLINICAL THERAPEUTICS 2010; 32:221-237, Review.
Hadjigeorgiou GM, et al. Low RLS prevalence and awareness in central Greece: an epidemiological survey. EUROPEAN JOURNAL OF NEUROLOGY 2007; 14:1275-1280, Article.
Department of Neurology, Faculty of Medicine, University of Athens (Assoc. Prof. L. Stefanis)
Biomedical Research Foundation of the Academy of Athens (Dr D. Vassilatis)
Institute of Child Health (Dr. H. Michelakaki)
Bozi M, et al. Genetic assessment of familial and early-onset Parkinson's disease in a Greek population. EUR J NEUROL 2014;21(7):963-8
Michalakaki E, et al. Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease. MOVEMENT DISORDERS 2012; 27(3):400-405 Article.
Moraitou M, et al. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson’s Disease. MOLECULAR GENET METABOLISM 2011;204(1-2):149-152 Article.
Xiromerisiou G, et al. Lack of association of the UCHL-1 gene with Parkinson’s disease in a Greek cohort: a haplotype tagging approach. MOVEMENT DISORDERS (Mov Disord. 2011 May 28. doi: 10.1002/mds.23694) Letter.
Department of Neurology, Faculty of Medicine, University of Crete (Prof. A. Plaitakis)
Plaitakis A, et al. Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson’s disease onset. EUROPEAN JOURNAL OF HUMAN GENETICS 2010; 18:336-341. Article
Collaboration with international research centers and universities
CELERA, Alameda, California, USA (Yonghong Li)
Li, et al. Neither Replication nor Simulation Supports a Role for the Axon Guidance Pathway in the Genetics of Parkinson's disease. PLOS ONE 2008; 3: e2707, Article.
Cyprus Institute of Neurology & Genetics (Directors: T. Kyriakides and K. Christodoulou)
Dardiotis E, et al. Intraperitoneal melatonin is not neuroprotective in the G93ASOD1 transgenic mouse model of familial ALS and may exacerbate neurodegeneration. NEUROSCI LETT 2013;548:170-5
Dardiotis E, et al. A correlative study of quantitative EMG and biopsy findings in 31 patients with myopathies. ACTA MYOL 2011 Jun; 30(1):37-41. Article
Nicolaou P, et al. Charcot-Marie-Tooth disease in Cyprus: epidemiological, clinical and genetic characteristics. NEUROEPIDEMIOLOGY. 2010; 35(3):171-177. Article
Daiou C, et al. Absence of aprataxin gene mutations in a Greek cohort with sporadic early onset ataxia and normal GAA triplets in frataxin gene. NEUROLOGICAL SCIENCES 2010;31:393-397, Article.
Dardiotis E, et al. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met. JOURNAL OF THE NEUROLOGICAL SCIENCES 2009;284:158-162, Article.
Dardiotis E, et al. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. AMYLOID 2009;16:32-37, Article.
Kyriakides T, et al. A comparative morphological study in 33 cases of respiratory chain encephalomyopathies. ACTA MYOLOGICA 2003;22:48-51, Article.
Columbia University, NY, USA (Prof. S. DiMauro και Assoc. Prof. N. Scarmeas)
Dardiotis E, et al. Alpha-1 antichymotrypsin gene signal peptide A/T polymorphism and primary intracerebral hemorrhage. EUROPEAN NEUROLOGY 2008; 59:307-314, Article.Scarmeas N, et al. Disruptive Behavior as a predictor in Alzheimer disease. ARCHIVES OF NEUROLOGY 2007; 64:1755-1761, Article.
Hadjigeorgiou GM, et al. Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions. JOURNAL OF ORTHOPAEDICS RESERCH 2007; 25:1087-1093, Article.
Hadjigeorgiou GM, et al. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset. MOVEMENT DISORDERS 2006; 21:534-539, Article.
Scarmeas N, et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. ARCHIVES OF NEUROLOGY 2005; 62:1601-1608, Article.
Scarmeas N, et al. Motor signs predict poor outcomes in Alzheimer disease. NEUROLOGY 2005; 64:1696-1703, Article.
Hadjigeorgiou GM, et al. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury.NEUROLOGY 2005; 65:1077-1082, Article.
Scarmeas N, et al. Motor signs during the course of Alzheimer disease. NEUROLOGY 2004; 63:975-982, Article.
Hadjigeorgiou GM, et al. Molecular genetic study of myophosphorylase deficiency (McArdle's disease) in two Yemenite-Jewish families. NEUROMUSCULAR DISORDERS 2002; 12: 824-827, Article.
Hadjigeorgiou GM, et al. A new stop codon mutation (Y52X) in the myophosphorylase gene in a Greek patient with McArdle's disease. JOURNAL OF THE NEUROLOGICAL SCIENCES 2002; 194:83-86, Article.
Nishino I, et al. Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phsphorylase mutations. ANNALS OF NEUROLOGY 2000; 47: 792-800, Article.
Department of Molecular Neuroscience, Institute of Neurology, UCL, UK (H. Houlden)
Xiromerisiou G, et al. THAP1 mutations in a Greek primary blepharospasm series. PARKINSONISM RELAT DISORD 2012 Oct 1, [Epub ahead of print] PubMed PMID: 23036512. Article
Department of Neurology, University of Milano, Milano, Italy (Prof. N. Bresolin and Prof. G.P. Comi)
Virgilio R, et al. Novel Twinkle (PE01) gene mutations in mendelian progressive external ophthalmoplegia. JOURNAL OF NEUROLOGY 2008; 255:1384-1391, Article.
Crimi M, et al. A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality.PEDIATRIC RESEARCH 2004; 55:842-846, Article.European Restless Legs Syndrome Study Group (EURLSSG)
Schormair Β, et al. MEIS1 and BTBD9 - genetic association with RLS in ESRD patients. JOURNAL OF MEDICAL GENETICS 2011; 48(7):462-466. Article.
Hogl B, et al. Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome:results of a prospective multi-center study. JOURNAL OF NEUROLOGY 2010; 257:230-237, Article.
Kemlink D, et al. Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. NEUROGENETICS 2008; 9:75-82, Article.
Winkelmann J, et al. Genetics of restless legs syndrome (RLS): State-of-the-art and future directions. MOVEMENT DISORDERS 2007; 22:S449-S458, Review.
Trenkwalder C, et al. Clinical trials in restless legs syndrome - Recommendations of the European RLS study group (EURLSSG).MOVEMENT DISORDERS 2007; 22: S495-S504, Review.
Garci-Borreguero D, et al. Validation of the Augmentation Severity Rating Scale (ASRS): A multicentric, prospective study with levodopa on restless legs syndrome. SLEEP MEDICINE; 2007; 8:455-463, Article.
Genetic Epidemiology of Parkinson’s disease Consortium (GEO-PD) (Prof. DM. Maraganore)
Puschmann A, et al. Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement. PARKINSONISM RELAT DISORD 2015;21(7):675-82
Theuns J, et al. Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. NEUROLOGY 2014;83(21):1906-13
Heckman MG, et a;. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. NEUROBIOL AGING 2014;35(1):266.e5-14
Chung SJ,et al. Alpha-synuclein repeat variants and survival in Parkinson's disease. MOV DISORD 2014;29(8):1053-7
Heckman MG, et al. Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. MOV DISORD 2013;28(12):1740-4
Sharma M, et al. large-scale replication and heterogeneity in Parkinson disease genetic loci. NEUROLOGY 2012; 14:79(7):659-667. Article
Sharma M, et al. A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J MED GENET 2012;49(11):721-6
Ross OA, et al. Association of LRRK2 exonic variants with susceptibility to Parkinson’s disease: a case-control study. LANCET NEUROLOGY 2011;10(10):898-908. Article.
Elbaz A, et al. Independent and joint effects of the MAPT and SNCA genes in Parkinson’s disease. ANNALS OF NEUROLOGY 2011;69(5):778-792 Article.
Kruger R, et al. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson.NEUROBIOLOGY OF AGING 2011;32(3):548.e9.18 Article.
Evangelou E, et al. Non-Replication of Association for Six Polymorphisms From Meta-Analysis of Genome-Wide Association Studies of Parkinson's Disease: Large-Scale Collaborative Study. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 2010;153B:220-228, Article.
Elbaz A, et al. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. LANCET NEUROLOGY 2006;5:917-923, Article.
Maraganore DM, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 2006;296:661-670, Article.
Laboratory of Neurogenetics, NIH/NIA, Bethesda, USA (A. Singleton, J. Hardy)
Kara E, et al. Assessment of Parkinson's disease risk loci in Greece. NEUROBIOL AGING 2014;35(2):442.e9-442.e16
Nalls MA, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. NAT GENET 2014;46(9):989-93
Nalls MA, et al. NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases. NEUROBIOL AGING 2015;36(3):1605.e7-12.
Xiromerisiou G, et al. Association between AKT1 gene and Parkinson's disease: A protective haplotype. NEUROSCIENCE LETTERS 2008;436:232-234, Article.
Fung HC, et al. Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts. NEURODEGENERATIVE DISEASES 2006;3:327-333, Article.
Hadjigeorgiou GM, et al. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset. MOVEMENT DISORDERS 2006;21:534-539, Article.
Clarimon J, et al. Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients. BMC NEUROLOGY 2005;5: 11, Article.
Scholz SW, et al. The human prion gene M129V polymorphism is not associated with idiopathic Parkinson's disease in three distinct populations.NEUROSCIENCE LETTERS 2006;395:227-229, Article.
Paisan-Ruiz C, et al. Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium.JOURNAL OF MEDICAL GENETICS 2006;43:e9, Article.